Skip to content
ppharmaranks
Menu

monistat dual- pak

Monistat Dual- Pak (Miconazole Nitrate) is an azole antifungal used to treat Aspergillosis, Cutaneous Candidiasis, Vulvovaginal Candidiasis, Tinea Pedis.

Miconazole Nitrate · by Personal Prods

Not yet rated· sourced from the FDA label
Rated against independent regulatory sources·Last updated June 7, 2026·How we rate
Verified againstopenFDANIH DailyMedRxClass
Compare online visit prices →We may earn a commission · never affects ratings

Key facts

Active ingredient
Miconazole Nitrate
Form
Topical, Suppository
Strength
Miconazole Nitrate 1.2GM
Type
Prescription (Rx)
Brand or generic
Brand-name
Manufacturer
Personal Prods
FDA application
NDA020968
Availability
Discontinued (per FDA)

Drug class

How this class works, per Antifungal Ergosterol Synthesis Inhibitors — StatPearls, NCBI Bookshelf (NIH).

May treat (source: NIH RxClass)

See how Monistat Dual- Pak ranks — best-rated azole antifungal for:

Dosage forms

Topical and Suppository

The forms currently marketed in the U.S., per the FDA National Drug Code Directory.

Ways to save

Ask for the generic

Same active ingredient, far cheaper. Is there a generic? →

Request a 90-day supply

Bulk fills usually lower the per-dose price vs monthly refills.

Use copay cards

Manufacturer copay cards & patient-assistance programs — especially for brand drugs.

Compare alternatives

A same-class option may cost less. See alternatives →

Frequently asked questions

What does Monistat Dual- Pak treat?
Monistat Dual- Pak (Miconazole Nitrate) may be used to treat aspergillosis, cutaneous candidiasis, vulvovaginal candidiasis, tinea pedis, tinea versicolor, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
How does Monistat Dual- Pak work?
Monistat Dual- Pak is a azole antifungal. Azole antifungals block a fungal enzyme (lanosterol 14-alpha-demethylase) that the fungus needs to make ergosterol, a key building block of its cell membrane. Without enough ergosterol the membrane becomes leaky and unstable, which stops the fungus from growing and can cause it to break apart and die.
Is there a coupon or discount for Monistat Dual- Pak?
pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Monistat Dual- Pak. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
Who makes Monistat Dual- Pak?
Monistat Dual- Pak is marketed by Personal Prods. You can see Personal Prods's full profile, rating, and other products on pharmaranks.
Is Monistat Dual- Pak a brand-name or generic drug?
Monistat Dual- Pak is a brand-name product with the active ingredient Miconazole Nitrate.
Is Monistat Dual- Pak available over the counter?
No. Monistat Dual- Pak is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
What forms does Monistat Dual- Pak come in?
Monistat Dual- Pak is currently marketed as topical and suppository, per the FDA's National Drug Code Directory.
What class of drug is Monistat Dual- Pak?
Monistat Dual- Pak is classified as azole antifungal, per the FDA's Established Pharmacologic Class.
Is Monistat Dual- Pak FDA-registered?
Monistat Dual- Pak is on record with the U.S. FDA under application number NDA020968. You can verify this on its official FDA label.

Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.

What people report to the FDA about MICONAZOLE NITRATE

The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 6,701 reports naming MICONAZOLE NITRATE — the active ingredient in Monistat Dual- Pak, and the FDA flagged 49% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:

  • vulvovaginal burning sensation1,134 reports
  • vulvovaginal pain385 reports
  • vulvovaginal pruritus332 reports
  • vulvovaginal discomfort261 reports
  • nausea201 reports
  • diarrhoea192 reports
  • international normalised ratio increased181 reports
  • rash167 reports

Read these as a signal, not a rate. A report does not mean MICONAZOLE NITRATE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.

Source: openFDA drug/event (FAERS), retrieved September 25, 2026.

Reviews

No reviews yet. Be the first to write one.

Write a review

Reviews are user opinions, not medical advice. Consult a licensed professional.

People also viewed

Compare Monistat Dual- Pak head-to-head

More azole antifungal drugs

Identify a pill by its imprint →Check a drug interaction →Drug recalls →

Browse medications A–Z

Research products from A to Z, compare independent ratings, and find alternatives.